Diagnovet, Inc.

Diagnovet, Inc. is a US-based software company that specializes in AI-driven solutions for the veterinary sector, particularly enhancing the efficiency of ultrasound report generation for veterinary professionals. Founded in 2025 in San Francisco, US, Diagnovet, Inc. develops an AI platform that automates ultrasound reporting for veterinarians.

The company has secured USD 300,000 in pre-seed funding led by 500 Global on June 7, 2026. It has engaged in one total deal to date. Diagnovet's primary offering is an AI-powered platform designed to streamline the process of creating ultrasound reports for veterinary professionals. This technology significantly reduces the time required to generate accurate, professional reports—from approximately 45 minutes to under 5 minutes—allowing veterinarians to focus on patient care rather than documentation.

The AI has been trained on over 100,000 real-world cases, providing users with structured draft reports that include findings and clinical impressions. The platform supports various ultrasound studies, enabling veterinary teams to upload DICOM files directly from their devices for analysis. Diagnovet primarily serves veterinary clinics and hospitals, with a client base that spans various geographical markets, including North America and Europe. Diagnovet operates on a subscription-based revenue model, where veterinary clinics and individual practitioners pay for access to the AI report generation service.

The subscription structure accommodates different levels of usage, offering flexibility for small practices to larger veterinary hospitals. Clients can opt for a free trial period to experience the service before committing to a paid plan. Revenue is generated through direct transactions between Diagnovet and its clients as they utilize the platform for generating ultrasound reports. The efficiency and speed of report production are key selling points that enhance the value proposition for subscribers, driving adoption and continued use of the service.

Following the recent funding round in June 2026, Diagnovet, Inc. plans to utilize the USD 300,000 to accelerate product development, support market entry, and validate early sales efforts. The company is focused on expanding its offerings and enhancing its platform's capabilities. Specific new products and features are in development, with potential release dates to be announced as the company progresses.

Additionally, Diagnovet aims to enter new markets in North America and Europe to broaden its customer base by the end of 2026.